Eagle Health Investments LP Adaptive Biotechnologies Corp Transaction History

Eagle Health Investments LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $4.73 Million - $6.14 Million	607,000 Added 99.86%	1,214,860 $10.7 Million
Q4 2022 Feb 13, 2023	SELL	$6.26 - $9.34 $3.8 Million - $5.67 Million	-607,000 Reduced 49.96%	607,860 $4.64 Million
Q2 2022 Aug 11, 2022	BUY	$6.4 - $14.73 $1.28 Million - $2.95 Million	200,000 Added 19.71%	1,214,860 $9.83 Million
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $2.67 Million - $7.63 Million	264,100 Added 35.18%	1,014,860 $14.1 Million
Q4 2021 Feb 10, 2022	BUY	$25.17 - $36.85 $7.78 Million - $11.4 Million	309,294 Added 70.06%	750,760 $21.1 Million
Q3 2021 Oct 20, 2021	BUY	$30.02 - $39.87 $5.51 Million - $7.32 Million	183,639 Added 71.23%	441,466 $15 Million
Q2 2021 Jul 19, 2021	BUY	$32.22 - $44.59 $1.79 Million - $2.48 Million	55,607 Added 27.5%	257,827 $10.5 Million
Q1 2021 Apr 23, 2021	BUY	$37.26 - $67.74 $4.42 Million - $8.04 Million	118,685 Added 142.08%	202,220 $8.14 Million
Q4 2020 Feb 04, 2021	BUY	$45.01 - $65.47 $3.76 Million - $5.47 Million	83,535 New	83,535 $4.94 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

Stay updated on Eagle Health Investments LP with notifications on news.